179 related articles for article (PubMed ID: 37395672)
1. Comparison of an ID NOW COVID-19 Assay Used at the Point of Care to Laboratory-Based Nucleic Acid Amplification Tests.
Payne D; Williams C; Jacob J; Chastain-Potts S; Adjei M; Taye B; Montalvo S; Short L; Tran A
J Clin Microbiol; 2023 Jul; 61(7):e0041323. PubMed ID: 37395672
[TBL] [Abstract][Full Text] [Related]
2. Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer.
LeBlanc JJ; McCracken GR; Goodall B; Hatchette TF; Barrett L; Ross J; Davidson RJ; Patriquin G
Microbiol Spectr; 2022 Aug; 10(4):e0063922. PubMed ID: 35863036
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Visby medical COVID-19 point of care nucleic acid amplification test.
Katzman BM; Wockenfus AM; Kelley BR; Karon BS; Donato LJ
Clin Biochem; 2023 Jul; 117():1-3. PubMed ID: 34798145
[TBL] [Abstract][Full Text] [Related]
4. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.
Lee J; Song JU
J Med Virol; 2021 Jul; 93(7):4523-4531. PubMed ID: 33913533
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic accuracy of the ID NOW COVID-19 point of care test in acute hospital admissions.
Thompson A; Hettle D; Hutchings S; Vipond B; Veasey N; Grant K; Turner J; Hopes R; Steer J; Ravanan R; Williams OM; Muir P
J Clin Virol; 2024 Feb; 170():105634. PubMed ID: 38211537
[TBL] [Abstract][Full Text] [Related]
7. Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT).
Dorta-Gorrín A; Navas-Méndez J; Gozalo-Margüello M; Miralles L; García-Hevia L
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373381
[TBL] [Abstract][Full Text] [Related]
8. Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19.
Krause E; Puyskens A; Bourquain D; Brinkmann A; Biere B; Schaade L; Michel J; Nitsche A
Mol Cell Probes; 2021 Aug; 58():101742. PubMed ID: 33971264
[TBL] [Abstract][Full Text] [Related]
9. Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs.
Serei VD; Cristelli R; Joho K; Salaru G; Kirn T; Carayannopoulous MO; Uprety P
Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115208. PubMed ID: 33545455
[No Abstract] [Full Text] [Related]
10. Automated sample-to-answer centrifugal microfluidic system for rapid molecular diagnostics of SARS-CoV-2.
Malic L; Brassard D; Da Fonte D; Nassif C; Mounier M; Ponton A; Geissler M; Shiu M; Morton KJ; Veres T
Lab Chip; 2022 Aug; 22(17):3157-3171. PubMed ID: 35670202
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department.
NguyenVan JC; Gerlier C; Pilmis B; Mizrahi A; Péan de Ponfilly G; Khaterchi A; Enouf V; Ganansia O; Le Monnier A
J Clin Virol; 2021 Dec; 145():105021. PubMed ID: 34768231
[TBL] [Abstract][Full Text] [Related]
12. Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals.
Stokes W; Venner AA; Buss E; Tipples G; Berenger BM
Clin Microbiol Infect; 2023 Feb; 29(2):247-252. PubMed ID: 36096431
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2.
Moore NM; Li H; Schejbal D; Lindsley J; Hayden MK
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32461287
[TBL] [Abstract][Full Text] [Related]
14. Commercial Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Assays: Superior Analytical Sensitivity of cobas SARS-CoV-2 Relative to NxTAG CoV Extended Panel and ID NOW COVID-19 Test.
Jin R; Pettengill MA; Hartnett NL; Auerbach HE; Peiper SC; Wang Z
Arch Pathol Lab Med; 2020 Nov; 144(11):1303-1310. PubMed ID: 32649229
[TBL] [Abstract][Full Text] [Related]
15. Development and Clinical Application of a Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for SARS-CoV-2 Infection.
Hu X; Deng Q; Li J; Chen J; Wang Z; Zhang X; Fang Z; Li H; Zhao Y; Yu P; Li W; Wang X; Li S; Zhang L; Hou T
mSphere; 2020 Aug; 5(4):. PubMed ID: 32848011
[TBL] [Abstract][Full Text] [Related]
16. Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an example.
Kang T; Lu J; Yu T; Long Y; Liu G
Biosens Bioelectron; 2022 Jun; 206():114109. PubMed ID: 35245867
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2.
Bulterys PL; Garamani N; Stevens B; Sahoo MK; Huang C; Hogan CA; Zehnder J; Pinsky BA
J Clin Virol; 2020 Aug; 129():104427. PubMed ID: 32535398
[TBL] [Abstract][Full Text] [Related]
18. Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting.
Graham M; Muhi S; Hoang T; Ballard SA; McAuley J; Kwong JC; Williamson DA; Howden BP;
Pathology; 2021 Dec; 53(7):912-914. PubMed ID: 34561096
[No Abstract] [Full Text] [Related]
19. Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies.
Desai KT; Alfaro K; Mendoza L; Faron M; Mesich B; Maza M; Dominguez R; Valenzuela A; Acosta CD; Martínez M; Felix JC; Masch R; Smith JS; Gabrilovich S; Wu T; Plump M; Novetsky AP; Einstein MH; Douglas NC; Cremer M; Wentzensen N
Microbiol Spectr; 2021 Oct; 9(2):e0084621. PubMed ID: 34668736
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of water gargle samples for SARS-CoV-2 detection using Abbott ID NOW COVID-19 assay.
Lévesque S; Beauchemin S; Vallée M; Longtin J; Jacob-Wagner M; Dumaresq J; Dulcey C; Labbé AC
J Med Virol; 2022 Sep; 94(9):4522-4527. PubMed ID: 35535382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
